Straits Times Index
3,212.64 -6.36 (-0.20%) Nikkei
27,385.25 -34.36 (-0.13%) Hang Seng
19,915.68 -133.96 (-0.67%) FTSE 100
7,355.92 -143.68 (-1.92%) Bitcoin USD
27,647.93 +3.90 (+0.01%) CMC Crypto 200
602.69 +5.23 (+0.88%)
Seagen Inc. (SGEN)
Pre-market:
| Previous close | 198.37 |
| Open | 199.43 |
| Bid | 197.00 x 900 |
| Ask | 0.00 x 800 |
| Day's range | 197.98 - 199.71 |
| 52-week range | 105.43 - 202.86 |
| Volume | |
| Avg. volume | 1,352,826 |
| Market cap | 37.067B |
| Beta (5Y monthly) | 0.53 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -3.27 |
| Earnings date | 26 Apr 2023 - 01 May 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 212.40 |
- Zacks
CRISPR Therapeutics AG (CRSP) Down 13.6% Since Last Earnings Report: Can It Rebound?
CRISPR Therapeutics AG (CRSP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Zacks
Why Is Seattle Genetics (SGEN) Up 24.6% Since Last Earnings Report?
Seattle Genetics (SGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Business Wire
Seagen to Present New Clinical and Preclinical Data From Broad Portfolio of Targeted Cancer Therapeutics at the 2023 AACR Annual Meeting
BOTHELL, Wash., March 14, 2023--Seagen Inc. (Nasdaq: SGEN) today announced the presentation of 17 abstracts featuring new clinical and preclinical data at the upcoming American Association for Cancer Research (AACR) Annual Meeting taking place in Orlando from April 14-19, 2023. The broad range of data being presented at this year’s meeting includes research from Seagen’s approved medicines, as well as data from early-stage clinical, preclinical, and discovery research programs.
